D
Daewoong Co Ltd
KRX:003090
Daewoong Co Ltd
KRX:003090
Price:
22 200
KRW
-1.99%
Market Closed
Market Cap:
₩907.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Daewoong Co Ltd
KRX:003090
|
KR |
|
Lizhi Inc
NASDAQ:SOGP
|
CN |
|
ACS Actividades de Construccion y Servicios SA
F:OCI
|
ES |
|
Sasken Technologies Ltd
NSE:SASKEN
|
IN |
|
M
|
Makara Mining Corp
CNSX:MAKA
|
CA |
|
Dynex Capital Inc
NYSE:DX
|
US |
Multiples-Based Value
The Multiples-Based Value of one Daewoong Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 22 200 KRW, Daewoong Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Daewoong Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Daewoong Co Ltd Competitors
Daewoong Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Daewoong Co Ltd
KRX:003090
|
958.7B KRW | 0.5 | 5.5 | 4.2 | 5.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
